David Rescott

Stock Analyst at Baird

(1.32)
# 1982
Out of 5,441 analysts
79
Total ratings
Success rate
Average return
11 Stocks
Name Action PT Current % Upside Ratings Updated
PEN Penumbra
Maintains: Strong Buy
300 310
239.88 29.23% 31 Jul 30, 2025
EW Edwards Lifesciences
Maintains: Neutral
78 79
78.21 1.01% 5 Jul 25, 2025
BSX Boston Scientific
Maintains: Outperform
117 123
102.78 19.67% 8 Jul 24, 2025
HAE Haemonetics
Initiates Coverage On: Outperform
87
52.47 65.81% 1 Jun 26, 2025
MDT Medtronic
Maintains: Neutral
94 92
92.75 -0.81% 6 May 22, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
55 61
49.57 23.06% 4 May 8, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
111 110
84.05 30.87% 3 Apr 25, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
600 575
471.96 21.83% 3 Apr 23, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
81 80
79.97 0.04% 4 Jan 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
73 71
n/a n/a 8 Jan 16, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
25 26
15.39 68.94% 6 Dec 22, 2023